azosemide has been researched along with Cardiac Failure in 12 studies
azosemide : A sulfonamide that is benzenesulfonamide which is substituted at positions 2, 4, and 5 by chlorine, (2-thienylmethyl)amino and 1H-tetrazol-5-yl groups, respectively. It is a diuretic that has been used in the management of oedema and hypertension.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess the efficacy and safety of azosemide in patients with edema and ascites." | 9.11 | [Efficacy and safety of azosemide in patients with edema and ascites]. ( Chen, JZ; Hu, XS; Hu, YL; Huang, GZ; Huang, XS; Lin, WQ; Wu, ZG; Zhang, Y; Zheng, JC, 2005) |
| "A long-acting loop diuretic, azosemide, has been shown to improve long-term prognosis in patients with heart failure compared with a short-acting loop diuretic, furosemide." | 7.91 | Patients With CONgestive Heart Failure Benefit From Long-Term Treatment Effects With Novel Treatment Using Azosemide Compared With Furosemide Derived From Existing Retrospective Study Data: CONTENTED. ( Abe, S; Arikawa, T; Inami, S; Inoue, T; Kanaya, T; Nishikawa, R; Saito, F; Sakuma, M; Toyoda, S; Watanabe, R, 2019) |
| "We have previously reported that a long-acting loop diuretic, azosemide, reduces cardiovascular risks in patients with chronic heart failure (CHF) as compared with a short-acting one, furosemide, in Japanese Multicenter Evaluation of LOng- versus short-acting Diuretics In Congestive heart failure (J-MELODIC)." | 5.24 | Changes in brain natriuretic peptide in chronic heart failure patients treated with long-acting versus short-acting loop diuretics: J-MELODIC subanalysis. ( Akasaka, T; Daimon, T; Fukui, M; Hirano, Y; Hirotani, S; Ito, H; Kawabata, M; Masuyama, T; Nakatani, S; Ohte, N; Tsujino, T; Yamamoto, K, 2017) |
| "To assess the efficacy and safety of azosemide in patients with edema and ascites." | 5.11 | [Efficacy and safety of azosemide in patients with edema and ascites]. ( Chen, JZ; Hu, XS; Hu, YL; Huang, GZ; Huang, XS; Lin, WQ; Wu, ZG; Zhang, Y; Zheng, JC, 2005) |
| "We investigated the effects of a short-acting loop diuretic (furosemide) and a long-acting loop diuretic (azosemide) on heart rate variability, fluid balance, and neurohormonal responses in patients with mild to moderate chronic congestive heart failure." | 5.09 | Effects of short-acting and long-acting loop diuretics on heart rate variability in patients with chronic compensated congestive heart failure. ( Doba, N; Imai, Y; Nakayama, T; Sakuma, Y; Shiojima, K; Tomiyama, H; Watanabe, G; Yamamoto, A; Yoshida, H, 1999) |
| "A long-acting loop diuretic, azosemide, has been shown to improve long-term prognosis in patients with heart failure compared with a short-acting loop diuretic, furosemide." | 3.91 | Patients With CONgestive Heart Failure Benefit From Long-Term Treatment Effects With Novel Treatment Using Azosemide Compared With Furosemide Derived From Existing Retrospective Study Data: CONTENTED. ( Abe, S; Arikawa, T; Inami, S; Inoue, T; Kanaya, T; Nishikawa, R; Saito, F; Sakuma, M; Toyoda, S; Watanabe, R, 2019) |
| "We compared therapeutic effects of furosemide, a short-acting loop diuretic, and azosemide, a long-acting one, in hypertensive heart failure rats to test the hypothesis that long-acting diuretics are superior to short-acting types in heart failure." | 3.73 | Different effects of long- and short-acting loop diuretics on survival rate in Dahl high-salt heart failure model rats. ( Hori, M; Mano, T; Masuyama, T; Miwa, T; Nishio, M; Ohtani, T; Sakata, Y; Yamamoto, K; Yoshida, J, 2005) |
| "We evaluated the comparative effects of furosemide, a short-acting loop diuretic, and azosemide, a long-acting loop diuretic, on neurohumoral factors and quality of life (QOL) in patients with congestive heart failure (CHF)." | 3.71 | Comparison of neurohumoral effects of short-acting and long-acting loop diuretics in patients with chronic congestive heart failure. ( Kinoshita, M; Maeda, K; Tsutamoto, T; Tsutsui, T, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 6 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kitada, S | 1 |
| Kikuchi, S | 1 |
| Tsujino, T | 3 |
| Masuyama, T | 4 |
| Ohte, N | 3 |
| Toyoda, S | 1 |
| Arikawa, T | 1 |
| Inami, S | 1 |
| Nishikawa, R | 1 |
| Saito, F | 1 |
| Watanabe, R | 1 |
| Sakuma, M | 1 |
| Kanaya, T | 1 |
| Abe, S | 1 |
| Inoue, T | 1 |
| Fukui, M | 1 |
| Hirotani, S | 1 |
| Ito, H | 2 |
| Yamamoto, K | 3 |
| Akasaka, T | 2 |
| Hirano, Y | 2 |
| Daimon, T | 2 |
| Nakatani, S | 2 |
| Kawabata, M | 1 |
| Harada, K | 1 |
| Izawa, H | 1 |
| Nishizawa, T | 1 |
| Hirashiki, A | 1 |
| Murase, Y | 1 |
| Kobayashi, M | 1 |
| Isobe, S | 1 |
| Cheng, XW | 1 |
| Noda, A | 1 |
| Nagata, K | 1 |
| Yokota, M | 1 |
| Murohara, T | 1 |
| Hisatake, S | 1 |
| Nanjo, S | 1 |
| Fujimoto, S | 1 |
| Yamashina, S | 1 |
| Yuzawa, H | 1 |
| Namiki, A | 1 |
| Nakano, H | 1 |
| Yamazaki, J | 1 |
| Miyata, M | 1 |
| Sasaki, T | 1 |
| Ikeda, Y | 1 |
| Shinsato, T | 1 |
| Kubozono, T | 1 |
| Furusho, Y | 1 |
| Kusumoto, A | 1 |
| Hamasaki, S | 1 |
| Tei, C | 1 |
| Origasa, H | 1 |
| Yoshida, J | 1 |
| Mano, T | 1 |
| Sakata, Y | 1 |
| Nishio, M | 1 |
| Ohtani, T | 1 |
| Hori, M | 1 |
| Miwa, T | 1 |
| Zhang, Y | 1 |
| Hu, XS | 1 |
| Chen, JZ | 1 |
| Wu, ZG | 1 |
| Huang, GZ | 1 |
| Hu, YL | 1 |
| Huang, XS | 1 |
| Lin, WQ | 1 |
| Zheng, JC | 1 |
| Tomiyama, H | 1 |
| Nakayama, T | 1 |
| Watanabe, G | 1 |
| Shiojima, K | 1 |
| Sakuma, Y | 1 |
| Yamamoto, A | 1 |
| Imai, Y | 1 |
| Yoshida, H | 1 |
| Doba, N | 1 |
| Tsutsui, T | 1 |
| Tsutamoto, T | 1 |
| Maeda, K | 1 |
| Kinoshita, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Japanese Multicenter Evaluation of Long- Versus Short-acting Diuretics in Congestive Heart Failure[NCT00355667] | Phase 4 | 320 participants (Actual) | Interventional | 2006-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
9 trials available for azosemide and Cardiac Failure
| Article | Year |
|---|---|
The prognostic value of brain natriuretic peptide in patients with heart failure and left ventricular ejection fraction higher than 60%: a sub-analysis of the J-MELODIC study.
Topics: Aged; Biomarkers; Cardiac Catheterization; Female; Follow-Up Studies; Heart Failure; Heart Ventricle | 2018 |
Changes in brain natriuretic peptide in chronic heart failure patients treated with long-acting versus short-acting loop diuretics: J-MELODIC subanalysis.
Topics: Aged; Aged, 80 and over; Biomarkers; Chronic Disease; Echocardiography; Female; Furosemide; Heart Fa | 2017 |
Beneficial effects of torasemide on systolic wall stress and sympathetic nervous activity in asymptomatic or mildly symptomatic patients with heart failure: comparison with azosemide.
Topics: Administration, Oral; Aldosterone; Cross-Over Studies; Delayed-Action Preparations; Drug Administrat | 2009 |
Comparative analysis of the therapeutic effects of long-acting and short-acting loop diuretics in the treatment of chronic heart failure using (123)I-metaiodobenzylguanidine scintigraphy.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Chronic Disease; Cross-Over Studies; Female; | 2011 |
Comparative study of therapeutic effects of short- and long-acting loop diuretics in outpatients with chronic heart failure (COLD-CHF).
Topics: Aged; Atrial Natriuretic Factor; Biomarkers; Chronic Disease; Delayed-Action Preparations; Echocardi | 2012 |
Superiority of long-acting to short-acting loop diuretics in the treatment of congestive heart failure.
Topics: Aged; Aged, 80 and over; Chi-Square Distribution; Chronic Disease; Disease-Free Survival; Female; Fu | 2012 |
[Efficacy and safety of azosemide in patients with edema and ascites].
Topics: Adolescent; Adult; Aged; Ascites; Diuretics; Double-Blind Method; Edema; Edema, Cardiac; Female; Hea | 2005 |
Rationale and design of a randomized trial to assess the effects of diuretics in heart failure: Japanese Multicenter Evaluation of Long- vs Short-Acting Diuretics in Congestive Heart Failure (J-MELODIC).
Topics: Adult; Aged; Aged, 80 and over; Delayed-Action Preparations; Diuretics; Furosemide; Heart Failure; H | 2007 |
Effects of short-acting and long-acting loop diuretics on heart rate variability in patients with chronic compensated congestive heart failure.
Topics: Blood Pressure; Cardiac Output; Chronic Disease; Cross-Over Studies; Diuretics; Echocardiography, Do | 1999 |
3 other studies available for azosemide and Cardiac Failure
| Article | Year |
|---|---|
Patients With CONgestive Heart Failure Benefit From Long-Term Treatment Effects With Novel Treatment Using Azosemide Compared With Furosemide Derived From Existing Retrospective Study Data: CONTENTED.
Topics: Aged; Aged, 80 and over; Disease Progression; Female; Furosemide; Glomerular Filtration Rate; Heart | 2019 |
Different effects of long- and short-acting loop diuretics on survival rate in Dahl high-salt heart failure model rats.
Topics: Animals; Echocardiography; Furosemide; Heart Failure; Interleukin-1; Norepinephrine; Rats; Rats, Inb | 2005 |
Comparison of neurohumoral effects of short-acting and long-acting loop diuretics in patients with chronic congestive heart failure.
Topics: Administration, Oral; Aged; Chi-Square Distribution; Chronic Disease; Diuretics; Dosage Forms; Femal | 2001 |